Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Renal Cell Carcinoma (mRCC)”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)UnknownNCT01274273
What this trial is testing

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Aarhus 118
Not applicableNot Yet RecruitingNCT07233668
What this trial is testing

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)
Seoul National University Hospital 172
Testing effectiveness (Phase 2)Study completedNCT02599779
What this trial is testing

A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

Who this might be right for
Stage IV Renal Cell Cancer AJCC V7
Sunnybrook Health Sciences Centre 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025
What this trial is testing

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
City of Hope Medical Center 34
Testing effectiveness (Phase 2)Study completedNCT00556049
What this trial is testing

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaNeoplasm Metastases
Massachusetts General Hospital 72
Early research (Phase 1)Study completedNCT01152801
What this trial is testing

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)Study completedNCT01896271
What this trial is testing

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT01157091
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
City of Hope Medical Center 28
Not applicableLooking for participantsNCT04712305
What this trial is testing

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
National Taiwan University Hospital 400
Early research (Phase 1)Study completedNCT01482156
What this trial is testing

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Breast CancerMetastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 46
Not applicableEnded earlyNCT03140176
What this trial is testing

Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 77
Early research (Phase 1)Study completedNCT04540705
What this trial is testing

Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 30
Not applicableStudy completedNCT05650164
What this trial is testing

Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)

Who this might be right for
Renal Cell Carcinoma
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 171
Testing effectiveness (Phase 2)Study completedNCT02019576
What this trial is testing

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Who this might be right for
Clear Cell Metastatic Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 38
Not applicableStudy completedNCT03538717
What this trial is testing

"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"

Who this might be right for
Carcinoma, Renal Cell
Pfizer 157
Not applicableStudy completedNCT00684645
What this trial is testing

Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 186
Not applicableLooking for participantsNCT05287464
What this trial is testing

International Multicentric Study ARON-1

Who this might be right for
Metastatic Renal Cell Carcinoma (mRCC)
Hospital of Macerata 1,220
Testing effectiveness (Phase 2)Study completedNCT02187302
What this trial is testing

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Who this might be right for
Metastatic Renal Cell Carcinoma
NewLink Genetics Corporation 115
Not applicableStudy completedNCT02086734
What this trial is testing

Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cancer
Ludwig-Maximilians - University of Munich 60
Not applicableEnded earlyNCT01033981
What this trial is testing

Cost Effectiveness Of Sunitinib In Central America And Caribbean

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 4
Next Page